Оценка эффективности использования Инотир® в сочетании с Белара® при синдроме поликистозных яичников

dc.contributor.author	Бекмирзаева Ф.М., Шукуров Ф.И.
dc.date.accessioned	2025-06-22T09:35:17Z
dc.date.available	2025-06-22T09:35:17Z
dc.date.issued	2019
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/1863
dc.description.abstract	60 patients with polycystic ovary syndrome were examined. The main group consisted of 40 women who received combination therapy with the multicomponent drug Inotir®, in combination with chlormadinone acetate, ethinyl estradiol containing (COC) Belara®. The control group included 20 healthy women of reproductive age. The use of combination therapy led to the normalization of the menstrual cycle, had an impact on the structure and volume of the ovaries, antiandrogenic action and normalization of carbohydrate metabolism.	en_US
dc.language.iso	other	en_US
dc.publisher	Tashkent, Uzbekistan	en_US
dc.subject	polycystic ovary syndrome; treatment; Inotir®, Belard®, violation of carbohydrate metabolism	en_US
dc.title	Оценка эффективности использования Инотир® в сочетании с Белара® при синдроме поликистозных яичников	en_US
dc.type	Article	en_US